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Accepted 12 March 2012AbstractObjective: Cancer cells reportedly have the ability to escape from the immune system, mainly from natural killer (NK) cells. Although the real
mechanisms are complicated, some inhibitors that are secreted from the cancer cells might play an important role. This study’s aim was to
investigate the potential mediator released by cancer cells (HeLa) that contributes to the decreased cytotoxicity of NK cells.
Methods and Materials: An NK-HeLa coculture system was used to test the hypothesis that the presence of the potential mediator from cancer
cells contributes to the decreased cytotoxicity of NK cells.
Results: After coculturing with HeLa cancer cells, the cytotoxicity of NK cells was decreased. When the coculture medium and culture medium
containing commercialized sialidase were used to culture NK cells, the cytotoxicity of the NK cells was also inhibited. However, cytotoxicity
was partially restored by a sialidase inhibitor (DANA). Western blot analysis of the HeLa cells after coculturing with NK cells demonstrated
increased Neu2 and Neu3 expression in HeLa cells.
Conclusions: The finding that Neu2 and Neu3 expression in cancer cells might be involved in the impaired function of NK cells, which could be
restored by a sialidase inhibitor, provides a new concept that could be applied to the management of cancer.
Copyright  2012, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Natural killer (NK) cells were initially identified as
a lymphoid population that represents 10e20% of peripheral
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doi:10.1016/j.tjog.2012.04.005players in the first line of defense against diseases because of
their ability to lyse major histocompatibility complex class I
(MHC-I)-negative tumors and virus-infected cells and
orchestrate the innate immunity of the organism. The rapid
cytotoxic actions and broad target range suggest that NK cells
may be promising candidates for use in cancer cell therapy,
with the potential to target a wide range of malignancies [1].
However, cancer cells often escape from NK cells, which
results in therapeutic failure. Although the tumor escape
mechanisms developed by cancers are complicated and
uncertain, some of them could be explained by inhibitors that
are secreted from cancer cells [2]. The restoration of immunecs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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particularly in regard to the residual disease [3]. Therefore,
restoration of the cytotoxicity of the NK cells by blockage or
neutralization of these cancer cell-secreting inhibitors might
provide be valuable for use in cancer treatment.
In this report, we used a coculture system that mixed NK
cells and cancer cells (a cervical cancer HeLa cell line) to
investigate the possible mechanisms of tumor-induced
immunosuppression.
Materials and methodsCell linesA human cervical cancer cell line, HeLa, was obtained
from the Culture Collection and Research Center, Food
Industry and Development Institute, Taiwan. HeLa cells were
grown in DMEM (GibcoBRL, Grand Island, NY, USA) that
was supplemented with 10% fetal bovine serum (FBS). The
NK-sensitive cell line, K562, was cultured in RPMI 1640
(GIBCO BRL) that was supplemented with 10% FBS. All cell
types were cultured in 10-cm dishes at 37C in a humidified
atmosphere with 5% CO2. Cell number and viability were
determined by staining with trypan blue, and the cell count
was determined using a hemocytometer (MARIENFELD/
MATSUNAMI, Germany).NK cellsPBMCs were separated from leukapheresed adult periph-
eral blood by Ficoll-Hypaque density gradient centrifugation
(Amersham Biosciences, GE Healthcare Life Sciences. Pis-
cataway, NJ, USA) [4]. PBMCs were resuspended at
a concentration of 106 cells/mL and cultured for 18 days.
Then, the NK cells were isolated from the PBMCs by auto-
MACS (NK Isolation Kit; Miltenyi Biotec, Germany) and
cultured for 1 day. The PBMCs and NK cells were maintained
in RPMI 1640 medium that was supplemented with 10% FBS
and 1000 U/mL recombinant human interleukin (IL)-2
(PeproTech Asia, Israel) at 37C in a humidified atmosphere
with 5% CO2.Interactions between NK and HeLa cellsA constant number of NK cells were directly cultured with
the HeLa cells (at a 1:1 ratio) for 1.5 hours or 3.5 hours at
37C in the NK-HeLa coculture system. Meanwhile, the cells
were also treated with or without DANA (sodium 5-
Acetamido-2,6-anhydro-2,3-dehydro-3,5-dideoxy-D-glycero-
D-galactononanoate; DANA, CALBIOCHEM, La Jolla, CA,
USA).Cytotoxicity assayK562 cells were incubated with 100 mCi of 51Cr for 60
minutes at 37C and then extensively washed with medium to
remove any free 51Cr. These radiolabeled target cells wereseeded onto round-bottom 96-well microplates, then the NK
cells or NK-HeLa cells were cultured with radiolabeled K562
cells (E:T ratio of 1:1) and incubated for 3 hours at 37C.
Supernatants containing the 51Cr that was released from the
lysed targets were collected and the radioactivity was counted
using a Packard gamma counter (PerkinElmer Inc., United
States). All experiments were repeated at least three times.
Percent-specific cytotoxicity was calculated according to the
formula: (sample 51Cr released e spontaneously released)/
(maximum amount released e amount spontaneously
released)  100 [5].Sialidase and DANA treatmentNK cells were suspended at a concentration of 106 cells/mL
in the RPMI 1640 medium and incubated in the presence or
absence of 0.2 U/mL sialidase (N-6514; Sigma, St. Louis,
MO, USA) and different doses of 1mM or 2mM DANA for 2
hours at 37C followed by extensive washing with RPMI 1640
medium and 0.25% FBS.Detection of sialidase activity and expression of HeLa
cells in the coculture systemHeLa cells were seeded in 96well plate with 4104 cells/
well and fixed with cold methanol (100mL/well) for 5 minutes.
Then remove cold methanol and incubated with the substrate
100mL per well contained 1 mM of X-Neu5Ac and 0.1 M
sodium acetate (pH 4.8) and Fast Red Violet LB (0.1 mg/mL)
for 1 hour at 37C. The cells were then washed twice with PBS
and detected using a fluorescence reader (Molecular Devices
Corporation, SpectraMax M2, Molecular Devices, Sunyvale,
CA, USA) with excitation wavelengths ranging from
520e550 nm and an emission wavelength of 580 nm [6,7]. In
addition, the sialidase activity of the cocultured medium was
detected using an Amplex Red Neuraminidase (Sialidase)
Assay Kit (Invitrogen, San Diego, CA, USA), according to the
manufacturer’s recommendations.ImmunoblottingCells were homogenized and solubilized in SoluLyse-M
Protein Extraction Reagent (Genlantis, San Diego, USA).
The protein content was determined using the Bradford assay
(Bio-Rad Laboratories, Inc., California, USA). The cell lysates
were separated using SDS-PAGE and analyzed by immuno-
blotting with the respective antibodies using Western Light-
ning Chemiluminescence Reagent Plus (PerkinElmer,
California, USA) [8]. The blots were probed using monoclonal
anti-Neu2 antibody (Abnova, Taipei City, Taiwan) and anti-
Neu-3 mAb (MBL Japan, Nagoya, Japan), respectively.
Capture and analysis of the images of the protein bands was
performed by using an imaging system equipped with a CCD
camera (AlphaImager 2200; Alpha Innotech Corporation) and
quantified by software AlphaEaseTM (Alpha Innotech
Corporation, San Diego, CA, USA).
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software package (SPSS Science, Chicago, IL, USA). The
statistics are presented as the means standard deviation
(SD), and the n value of each group represents the individual
case number that was performed and, in each case, every
parameter was analyzed three times. Statistical analysis was
performed by one-way analysis of variance (ANOVA), fol-
lowed by an least significant difference (LSD) multiple range
test to analyze differences in the group means in comparison
with the control means. Statistical significance was defined as
p< 0.05, as indicated by an asterisk (*), and p< 0.01, as
indicated by a double asterisk (**).
ResultsCytotoxicity of the NK cells decreased after coculturing
with HeLa cellsIL-2 was added during the differentiation and proliferation
stages of theNK cells. During the culturing period, the cytotoxic
effects of the IL-2-activated NK cells on the K562 cells grad-
ually increased. To determine whether the cancer cells altered
the cytotoxicity of the NK cells, the non-cocultured NK cells or
NK cells were cocultured with HeLa cells for 1.5 or 3.5 hours to
determine the 3-hour cytotoxic effects on the K562 cells. The
results show that the cytotoxic abilities of the NK cells were
significantly decreased (75 8% in the 1.5-hour group and
70 8% in the 3.5-hour group, respectively; Fig. 1A).Increased sialidase activity of the cocultured medium
Fig. 1. (A) Cytotoxicity of cocultured NK cells. NK cells were cocultured with
HeLa cells for 1.5 or 3.5 hours, and then K562 cells were added and incubated
for an additional 3 hours. The cytotoxicity of the NK cells was measured
relative to the NKþHeLa cells in the 1.5- or 3.5-hour group. (B) Sialidase
activity of the cocultured medium. HeLa cells were cocultured with NK cells
for 1.5 or 3.5 hours, and then K562 cells were added and incubated for anThe sialidase activity of the cocultured medium was eval-
uated at 1.5 and 3.5 hours. As shown in Fig. 1B, the sialidase
activity increased by 20% and 40% after 1.5 and 3.5 hours of
incubation, respectively, in a time-dependent manner.additional 3 hours. After coculturing, the medium was collected and tested for
sialidase activity. Data on the cocultured medium is shown relative to the data
of the HeLa cell medium. **p< 0.01.Effect of sialidase and DANA on NK cytotoxicityThe cytotoxic abilities of the sialidase-treated and non-
treated NK cells were assessed to determine whether sialidase
reduces the cytotoxic ability of NK cells. The results reveal
that 0.2 U/mL sialidase does significantly impair the cytotoxic
ability of NK cells (Fig. 2). The neuraminidase inhibitor,
DANA (1 mM or 2 mM), did block the inhibitory effects of
sialidase in a dose-dependent manner, although the effects
were only partial (Fig. 2).Cytotoxicity of NK cells was partially restored by DANA
in the NK-HeLa coculture systemBased on the abovementioned findings, we determined (1)
decreased cytotoxicity of the NK cells in the NK-HeLa co-
culture system, (2) increased sialidase activity in the cocul-
tured medium, and (3) adding sialidase to the NK culture
system mimicked the cocultured medium in terms of theinhibitory effects on the cytotoxicity of the NK cells, which
could be partially restored by adding DANA. It is rational to
suppose that adding DADA to the NK-HeLa coculture system
would restore the cytotoxicity of NK cells. Therefore, we
added 1 or 2 mM DANA to the NK-HeLa coculture system
and, as predicted, we found that DANA did restore the cyto-
toxic ability of the NK cells in the NK-HeLa coculture system,
ranging from 10e25% in a dose- and time-dependent manner,
although the effect was not significant in the 1.5-hour group,
regardless of the concentration of DANA (Fig. 3AeB).Sialidase activity of the HeLa cells after coculturing
with NK cellsThe sialidase activity of the HeLa cells in the coculture
system was determined using a fluorometric assay that used
Fig. 2. Cytotoxicity of the NK cells treated with sialidase (SA) or sialidase
inhibitor (DANA). NK cells were treated with 0.2 U/mL SA or 1 mM or 2 mM
DANA at 37C for 2 hours. NK cells were then cocultured with 51Cr-labeled
K562 tumor cells at E:T cell ratios of 1:1 for 3 hours. The cytotoxicity of the
treated NK cells is shown relative to cytotoxicity of nontreated NK cells.
*p< 0.05; **p< 0.01.
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(control), sialidase activity of the HeLa cells which were
cultured with NK cells for 1.5hour or 3.5hour increased 1.4 
0.4 and 1.6  0.4-fold, respectively, suggesting that the sia-
lidase secreted from HeLa cells might decrease the cytotoxic
effects of NK cells (Fig. 4A).Increased Neu2 and Neu3 expression of the HeLa cells
in the coculture systemFig. 3. NK cell cytotoxicity relative to NKþHeLa cells in the 1.5- or 3.5-hour
groups. NK cells were cocultured with HeLa cells with or without DANA for
(A) 1.5 hours or (B) 3.5 hours, then K562 cells were added and incubated for
an additional 3 hours. The cytotoxicity of the DANA-treated groups is shown
relative to the cytotoxicity of the group that was not treated with DANA.
*p< 0.05.Using Western blot analysis, we further evaluated the
protein expression levels of the HeLa cells after coculturing
with NK cells. In agreement with the enzyme activity of the
sialidase expression of Neu2 and Neu3 in the HeLa cells after
coculture with NK cells, the expression levels of Neu2 protein
were increased by 22% and 33% in the 1.5-hour and 3.5-hour
groups, respectively, in the HeLa cells after coculture with NK
cells in comparison with the controls (Fig. 4B). The expression
level of Neu3 protein in the HeLa cells was also increased
24% and 42% in the 1.5-hour and 3.5-hour groups, respec-
tively (Fig. 4C).
Discussion
Changes in the immune system can be a consequence of an
underlying malignancy or they can be induced by antineo-
plastic treatment [9]. Both affect the risk of infectious
complications and relapse. Over the past decade, there have
been a series of major developments in the laboratory
assessment of immune dysfunction, particularly as it relates to
the complex interactions between distinct components of the
immune system [9]. Among these assessments, the use
a coculture system might be a good tool for evaluating the
interactions between NK and cancer cells. We could use thissystem to evaluate the candidate mediators and investigate the
potential candidate molecules that can restore the original
conditions because the restoration of immune functions is of
great importance to tumor eradication, and we should be able
to overcome the various tumor escape mechanisms that have
developed in cancer cells. In this study, we used the NK-HeLa
coculture system to clearly demonstrate that the cytotoxicity
of NK cells is impaired by HeLa cancer cells. The inhibitory
effect of the NK-HeLa coculture system suggests that the
interactions between NK and HeLa cancer cells do occur and
that the HeLa cancer cells might have affected the NK cells,
thereby contributing to the tumor escape mechanisms. We
suppose that the HeLa cancer cells might have secreted some
mediators, which are involved in the decreased cytotoxicity of
the NK cells. Therefore, the culture medium of the NK cells,
with and without HeLa cancer exposure, might provide us
Fig. 4. (A) Sialidase activity of HeLa cells. HeLa cells were cocultured with NK cells for 1.5 or 3.5 hours, and then K562 cells were added and incubated for an
additional 3 hours. After coculturing, the HeLa cells were fixed and tested for sialidase activity. The value of the cocultured HeLa cells is shown relative to HeLa
cells. (B, C) Western blot analysis of the HeLa cells. 1) HeLa only; 2) HeLa cells cocultured with NK cells for 1.5 hours; 3) HeLa cells cocultured with NK cells for
3.5 hours. Protein expression levels were measured in the HeLa cells. 1) HeLa cells only; 2) HeLa cells cocultured with NK cells for 1.5 hours and 3) HeLa cells
cocultured with NK cells for 1.5 hours or 3.5 hours. K562 cells were added and incubated for an additional 3 hours. *p< 0.05.
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culture medium of the NK cells, with and without HeLa
cancer cells, and found many candidate molecules, including
cytokines and proteins, that were elevated in the coculture
medium. Many of these, including IL-6 and matrix metal-
loproteinases (MMPs; especially MMP 2 and 9), have been
previously reported [10,11]. Among the increased molecules
that were identified in the coculture medium in this study,
sialidase attracted us because sialidases remove sialic acids
and greatly influence many biological processes by changing
the conformations of glycoproteins, thereby affecting recog-
nition and masking the biological sites of functional molecules
[12]. Therefore, cellular functions and behaviors will be
changed if an alteration to sialylation occurs [13,14]. It is
rational to suppose that sialidases might be possible mediators
by decreasing the cytotoxicity of NK cells when NK cells are
exposed to HeLa cancer cells because killer lectin-like
receptors on NK cells mediate cytotoxicity via the glycans
on the target cells [15]. In this study, we used different strat-
egies, including the use of a coculture medium, to replace the
culture medium of the NK cells and administer commercial-
ized sialidase into the culture medium of the NK cells. We
found that the cytotoxicity of NK cells was indeed impaired,
and that this inhibitory effect could be restored by the
administration of a neuraminidase inhibitor (in this study,
DANA), supporting the hypothesis that the sialidase in the
NK-HeLa coculture system contributed to the decrease in the
cytotoxicity of the NK cells. However, the origin of sialidase is
still uncertain. The sialidase activities of the NK and HeLa
cells in the coculture system were checked, and we found that
the sialidase activity of the HeLa cells was increased, which
suggests that the sialidase in the coculture medium originated
from the HeLa cells. Western blot analysis further confirmed
the increased expression of sialidases in the HeLa cells in the
coculture system and that the types of sialidases were Neu2
and Neu3.
The relationship between the sialidases and cancer has been
extensively reviewed by Miyagi [10]. Sialidases are glycosi-
dases that catalyze the removal of a-glycosidically linked sialic
acid residues from the terminal positions of the carbohydrate
groups of glycoproteins and glycolipids, which is the initial step
in the degradation of these glycoconjugates [10,12]. Sialidase
activity may be implicated in cellular growth and differentia-
tion, neoplastic transformation, and possibly cell-to-cell inter-
actions [16e18]. There are four types of mammalian sialidases
that have been identified and characterized so far: these are
designated as Neu1, Neu2, Neu3, and Neu4. The first three are
localized predominantly in the lysosomes, cytosol, and plasma
membranes, respectively, and the fourth, Neu4, is a recently
identified sialidase that has been suggested to exist in lyso-
somes, mitochondria, and certain intramembranous compo-
nents [10]. Among these sialidases, Neu3 has been most often
found to be elevated in various kinds of cancer cell lines,
including renal cancer, colon cancer, and cervical cancer cell
lines [10,19e23]. In this study, we also found that the exposure
of HeLa cells to NK cells further increases the expression of
Neu2 and Neu3, and that Neu2 and Neu3, at least partially, aresecreted by HeLa cells after coculture with NK cells. Therefore,
the use of DANA (a neuraminidase inhibitor) could success-
fully restore the inhibitory effects of NK cells in a medium that
has been supplemented with sialidase. However, the adminis-
tration of DANA could only partially restore the cytotoxicity of
NK cells in the NK-HeLa coculture system, suggesting that
other mediators might contribute to the decreased cytotoxicity
of the NK cells. We also found that IL-6 was elevated in the
coculture system (data not shown). IL-6 not only affects NK
cell functions [24], but also enhances Neu3 promoter luciferase
activity by 2.5-fold and significantly enhances endogenous
sialidase activity in human RCC ACHN cells [10]. Therefore,
the presence of at least IL-6 in the coculture mediummight also
contribute to the decreased cytotoxicity of NK cells.
We used PBMC NK cells as the effector cells in this study,
and this is the main limitation that requires further attention
because it was difficult to obtain an adequate number of NK
cells from one adult donor in order to perform all of the
experiments of this study. However, based on our findings, we
can still conclude that HeLa cancer cells increase the secretion
of sialidase (Neu2 and Neu3) while in coculture with NK cells,
and that the secretion of sialidase contributes to the decreased
cytotoxicity of NK cells. This inhibitory effect can be restored
by a neuraminidase inhibitor, suggesting that the use of sia-
lidase inhibitors might be valuable in the management of
cervical cancer. This sort of therapy would be helpful for the
restoration of immune functions in order to eradicate residual
tumors, which might not be completely cured by the various
kinds of established therapies already in use.
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